chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she woke up this morning with vomiting, loose stool and her chest wall muscles are extremely painful; she woke up this morning with vomiting, loose stool and her chest wall muscles are extremely painful; she woke up this morning with vomiting, loose stool and her chest wall muscles are extremely painful; nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know about her symptoms after receiving the covid 19 vaccine. The patient reported that she woke up this morning (an unspecified date) with vomiting, loose stool and her chest wall muscles were extremely painful, and she wanted advice on what to do about her nausea. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Raised, red, itchy rash around injection site exactly 8 days after vaccine. Rash is approx. 2 inch in wide/3 inch long. Has rough edges, feels rough to tough. Hot and itchy- has lasted 1 day so far.
Residual pain in lower arm still. More concerning is a loss of short-term memory recall. Particularly names. Seems to have progressed and stabilized but not improved until regular season flu shot taken when it became more severe again. Does not affect long-term memory. Some instances of "zoning out"/brain fog or lethargy. Lapses typically only lasts minutes. In some cases has lasted a few hours or over night. Eventually comes back. Worse when stressed or tired but is noticeable to  family and closer friends. No prior symptoms at all. Known for a very quick memory and recall. DOES agree with others I've talked to about their experience. Oddly in same age category.
Received MMR on 2/22/01, blood test (-) for measles antibodies. Works with children having a measles outbreak. On 3/3/01, she developed joint pain with left arm pain. On 3/6/01, had swollen axillary lymph nodes and redness at site of injection. Swollen and tender left breast. Seen by doctor on 3/8/01. On 3/9/01, arm is some better this AM. Treated with Advil and Chlor-Trimeton and ice to breast and arm.
approx 7 to 8 days post vax pt devel temp of 104.9 @ MD office temp dropped to 103.5-broke out in rash all over;dx w/roseola;
Excessive vomiting (6+ times) the day after receiving the vaccination. Couldn?t eat even one cracker or keep any water down. Went to the ER at 4pm, was given zofran and fluids through IV. Nausea subsided the following day but other symptoms (fatigue, fever, headache, muscle aches) persisted.
The next day I had a pain in my left ribs, heartburn, and stomach ache. I ended up going to the hospital after I couldn?t stand it any longer and mor Gi issues emerged. They diagnosed me with acute pancreatitis and the pain and gi symptoms are continuing, even now 6 weeks later.  It?s quite possibly caused me chronic pancreatitis at the age of only 28.
Guillane Barre Syndrome; It nearly killed him; struggles with numb hands and feet; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a 50-year-old male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced guillain barre syndrome (serious criteria hospitalization and GSK medically significant), near death experience (serious criteria hospitalization and GSK medically significant) and numbness of extremities. On an unknown date, the outcome of the guillain barre syndrome and near death experience were recovered/resolved and the outcome of the numbness of extremities was not recovered/not resolved.   It was unknown if the reporter considered the guillain barre syndrome, near death experience and numbness of extremities to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced Guillane Barre Syndrome from the flu shot. It nearly killed the patient. The patient was in ICU for weeks and the recovery process was months.  The patient was still struggles with numb hands and feet 5 years later.
COMPLAINT OF FEELING LIGHT HEADED AND DIZZY THAT EVENING AFTER THE VACCINE. AGAIN TODAY WHILE AT WORK FEELING LIGHTHEADED AND DIZZY
Very achy all over, sore at injection sight, flu like symptoms, headache, tired, dizzy
This spontaneous report as received from other health professional refers to a patient of unknown age. On 24-JUL-2017 the patient was vaccinated with an incorrect storage GARDASIL 9 lot # N004798, expiration date: 31-OCT-2018 and lot # M037770, expiration date: 01-JUL-2019, for prophylaxis. On an unknown date the patient experienced no adverse event. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA002800:
Severe exudative conjunctivitis lasting 24 hours and subsiding without treatment. Swelling in pharynx causing cough and dysphagia lasting 12 hours subsiding without treatment.
Child limping with left leg. Left leg was stiff. Taken to chiropractor on 12/23 and after adjustment child was back to normal by 12/27. However, on 1/8/04 child started limping with left leg again.
I had intensely puckered/tingling around my mouth and cheeks as well as tingling down both of my arms to both hands; I had intensely puckered/tingling around my mouth and cheeks as well as tingling down both of my arms to both hands; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 28May2021 14:30 (Lot number: EW0178) at the age of 58 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "HTN" (unspecified if ongoing), notes: HTN; "known allergies: Pineapple" (unspecified if ongoing), notes: known allergies: Pineapple. Concomitant medication(s) included: BENAZEPRIL HCL. The following information was reported: PARAESTHESIA (non-serious), PARAESTHESIA ORAL (non-serious) all with onset 29May2021 09:00, outcome "recovered" (29May2021) and all described as "I had intensely puckered/tingling around my mouth and cheeks as well as tingling down both of my arms to both hands". Therapeutic measures were not taken as a result of paraesthesia, paraesthesia oral.  Follow-Up (15Jul2021): Follow-up attempts are completed. No further information is expected.
left arm, 65 x 65 mil erythema, redness. No open areas, hot to touch. Instructed parent on Tdap administer S/E comforting meas.
PATIENT HAD SUDDEN ONSET OF NAUSEA, DIZZINESS AND EXPERIENCED 2-3 EPISODES OF VOMITTING FOLLOWING ONSET. PT ALSO COMPLAINS OF SINUS CONGESTION AND MILD BODY ACHES SINCE DATE OF VACCINATION.
Fever; Chills; Headache; Severe muscle and body aches; This is a spontaneous report from a contactable consumer. This 59-year-old female consumer (patient) reported that.  A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201), via an unspecified route of administration, administered in Arm Left on 13Feb2021 11:15 as (At the age of 59-years) dose number unknown, single for covid-19 immunisation. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. It was reported that 16 hours post vaccine (3AM), patient woke with a fever, chills, headache and severe muscle and body aches. Temp was 100.6 and patient normally run 97.5. This lasted for over 12 hours. At 1:30 PM on 14Feb2021 patient took two extra strength tylenol (which was 26 hours post vaccine). The patient underwent lab tests and procedures which included body temperature: 100.6 on 14Feb2021, normally run 97.5. The outcome of events was recovering.  Follow-up attempts completed. No further information expected.
severe itching in palms and soles of feet bilaterally, started 24 hours after vaccination.
Dose # 3 (booster ) was the dose of 5-11y (0.2ml) rather than 0.3ml
major muscle cramp in his right leg - followed by his eyes rolling back and slurred speech - it happened at 4:30 p.m., 5:30 pm and 7:30 pm - each time it lasted for several minutes
Patient was given Moderna bivalent booster past the beyond use date of 11/11/2022. Vaccine was administered on 11/14/2022. No signs or symptoms of adverse reaction.
Information has been received from a physician concerning a female who was vaccinated with 0.5 ml of Gardasil via injection.  The physician reported that after the patient received the shot she fainted.  Because of the fall the patient had a cut and had to received 6 stitches.  No lot number was provided and no further information was provided.  Additional information has been requested.
VACCINE WAS SHINGRIX, 2ND DOSE. HAD HEADACHE,CHILLS,FEVER BODY ACHES.
his first Menactra injection on 12/31/2013, the second injection March 16/ no AE.; Initial information received on 15-May-2019 regarding an unsolicited valid non-serious case received from a other health professional.   This case involves a 12 years old male patient who received his first injection of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] (Prefilled Syringes) on 31-DEC-2013 (lot: U4556AB; left deltoid) and second injection on 16-March-2016 (lot: U527AA, right deltoid) via intramuscularly.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  ADACEL vaccine was received as concomitant therapy.   It was of actual medication error case due to  extra dose administered. As per Product insert, 4 year interval should be there between two doses.  No adverse event was experienced.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Sudden onset of global weakness. Pt hospitalized and diagnosed with ADEM. Specialist believes the condition may have been caused by vaccines. 01/08/07-records received and reviewed.  DOS 11/29-12/9/06- DC DX: acute disseminating encephalopathy. Began with weakness not moving all 4 limbs, PE little movement in lower limbs, hypotonic, 2+reflexes, without clonus, poor head control. Two weeks prior had respiratory illness.  Treatment included Solu Medrol. Residual neurological symptoms - weakness of extremities, mild developmental delay (motor), and vesico-uretral reflux (possibly due to urinary retention).
Case number PHEH2014US022474 is an initial spontaneous report from the pharmacist received on 07 Nov 2014. This report refers to a female patient of an unknown age. The patient was vaccinated with FLUCELVAX (batch number: not reported) intramuscularly on 06 Nov 2014. It was reported that the vaccine ran out of the injection site. No adverse event reported followed this medication error (vaccine underdose).
Mother called clinic at 11am 9/16/2020  to alert nurse patient had an adverse reaction. she stated patient began to feel warm at 9pm on 9/15/2020 and she began to alternate Tylenol and ibuprofen at that time. She then stated patient had a temperature of 104.2 at 3am, then began having a seizure at 5:30am. An ambulance was called and arrived at 6am. Mother states patient has since been discharged from ER and they diagnosed him with febrile seizures.
Vaccinated (2 dose) patient admitted with positive COVID test through ED.  Dies of COVID complications.  Provider d/c note below:    "Patient was admitted on 12/1/2021 due to COVID pneumonia. She continued to decompensate over the course of her stay despite aggressive medical care and passed on 12/13/2021 at 17:52 due to COVID pneumonia and acute respiratory failure."
Breakthrough case admission after three vaccines Moderna 3/25/21 Lot# 028A21A;  Moderna 4/22/21 Lot# 002C21A;  Moderna; 1/25/22 Lot# 033H21A
After vaccine it was swollen up and I felt light headed, I laid down and as the days wen on I felt worse, I couldn't taste, body aches, chills, and bad headache and neck aches, I also had problems breathing. Also I'm still having headaches.
Violent shaking lasting 3 hours. Then exhausted for 24. Extreme muscle contractions and spasm, Rapid breathing, Teeth banging together.
Has erythema, tenderness, swelling-unduration and redness on left upper arm. 48 hours after immunization given motrin and benadryl. zero resp distress
she was so miserable; terrible headache; lips and tongue were burning; lips and tongue were burning; anaphylactic event; little nauseas/severe nausea/she was so nauseas/nausea was overwhelming; This is a spontaneous report from a contactable consumer (patient). A elderly (reported as almost 80 years old) female patient received the first dose of bnt162b2 (Lot/batch number and Expiration date were not provided), via an unspecified route of administration on 02Feb2021 13:30 at single dose for covid-19 immunization. Medical history included allergy to latex and shellfish (iodine), cancer, anaphylactic reaction she had 15-20 years ago where it was much worse and she could not swallow or breathe. The patient's concomitant medications were not reported. Patient received her 1st dose of the Pfizer covid vaccine. She is reported to have experienced severe nausea and terrible headache, lips and tongue were burning which she says reminds her of an anaphylactic reaction she had 15-20 years ago where it was much worse and she could not swallow or breathe. Patient would like to know whether her side effects are normal and her side effects post- vaccine whether they have been reported before. Patient would like to know if the 2nd shot of the covid vaccine is going to be worse and if the side effects after the 1st dose are going to be worse. She received the first COVID-19 vaccine on 02Feb2021. She felt fine until late that evening. She got a little nauseas. It just so happens the next day she was scheduled for her 3 month check-up with her internist. She told the doctor she was a little nauseas that last night, but was fine that day. She clarified further she received the COVID-19 vaccine on 1:30pm on 02Feb2021. Around 3:00pm on 03Feb2021, she was so nauseas, she was so miserable. She called the pharmacist and asked what could she possibly take. The pharmacist told her to drinks lots of water, drink Gatorade, and have her doctor order something to treat the nausea. Caller states she couldn't get a hold of her doctor. However, she did what the pharmacist told her to do by drinking water and Gatorade. The nausea was overwhelming. She got this terrible headache. Later in the day, her lips and tongue were burning. She thought to herself "oh my gosh, I'm having an anaphylactic event". She does keep an EpiPen on her. She took 2 Benadryl. She didn't know if she could take Advil and Benadryl at the same time, so she didn't do that.  She is in sort of panic to get the second shot. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
Swelling,  at the injection site.; tenderness at injection site; hot to touch; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th June 2020, the patient received Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced injection site swelling, injection site tenderness and skin warm. On an unknown date, the outcome of the injection site swelling, injection site tenderness and skin warm were unknown.   It was unknown if the reporter considered the injection site swelling, injection site tenderness and skin warm to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient experienced swelling, tenderness at the injection site. The arm was also hot to the touch. The reporter did not consent to follow up.
GOT COVID BREAKTHROUGH; SUSPECTED CLINICAL VACCINATION FAILURE; This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, start therapy date were not reported, administered for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, it was reported that "2 of my family did get the new Covid as a breakthrew. My sister felt sick only 3 days." On an unspecified date, the patient experienced got covid breakthrough, and suspected clinical vaccination failure.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got covid breakthrough and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with a product quality complaint: 90000215670. This case, from the same reporter is linked to 20220203948.; Sender's Comments: V0 20220204795-COVID-19 VACCINE AD26.COV2.S-got covid breakthrough. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). V0 20220204795-COVID-19 VACCINE AD26.COV2.S-suspected clinical vaccination failure . This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Severe tooth pain.  Especially sensitivity to cold in all four quadrants.; Severe tooth pain.  Especially sensitivity to cold in all four quadrants.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 02May2021 at 10:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient's relevant medical history was not reported. Concomitant medications included escitalopram oxalate (LEXAPRO); bupropion hydrochloride (WELLBUTRIN); omega-3-acid ethyl ester (LOVAZA) and fexofenadine (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EE0161) via an unspecified route of administration in the right arm on 11Apr2021 at 11:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 03May2021 at 09:00, the patient experienced severe tooth pain, especially sensitivity to cold in all four quadrants. It was reported as 9.9 out of 10 pain. The events resulted in a visit to the doctors or other healthcare professional office/clinic. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events severe tooth pain, especially sensitivity to cold in all four quadrants was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Prevnar given in right vastus lateralis intramuscularly with 1 inch retractable syringe.  About 10 minutes later mother said the baby's leg looked red and funny.  The skin to above the left knee was red like a scald would look.  The baby had a high-pitched scream/cry.
pt recv vax 19SEP95 & 2DEC97 pt exp a breakthrough case of chickenpox;it was reported that the amount of lesions were unk, but was completely covered w/chickenpox;
Patient given Dtap after age 6 age 8  Lot # U1813BA.
I received my booster 2/18/2022 as mandated. That night I awoke at 11 pm out of a sound sleep. I suffered terribly: severe rigor, severe arthralgia and myalgia for hours. My fingers swelled. I was able to remove one ring but not another. I had some tightness in my chest. I had to take a prescription strength NSAID (recently prescribed by my MD for persistent headaches post COVID-19 infection 12/24/2021). The worst of the symptoms subsided after 48 hours. I can only hope the now milder arthralgia, myalgia and headaches resolve.
On 1/24/2023 patient reported that he received an influenza vaccine at our clinic on 10/06/2022. Patient stated that he has been receiving physical therapy due to the vaccine being administered to high.
feeling pain; inflammation Sunday night, beside my armpit, almost in my back; shingles; This is a spontaneous report from a contactable consumer (patient) reported for self. A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), via an unspecified route of administration, at the age of 65 years (for confirmation), on 02Mar2021 as 1ST DOSE, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated, "I received the first dose of the Covid 19 vaccine on 02Mar2021. I started feeling pain and inflammation Sunday night (07Mar2021), beside my armpit, almost in my back. On Monday (Mar2021) the pain got worst. I went to my doctor and she told me to it was shingles and that it was one of the effects of the vaccine." The outcome of the events was unknown.  Information on the lot/ batch number has been requested.
Information has been received from a 26 year old female for GARDASIL a Pregnancy Registry product, who on 08-JUN-2010 was vaccinated with a first dose of GARDASIL (route and lot number unspecified). On 08-JUL-2010, the patient was vaccinated with a second dose of GARDASIL (route and lot number unspecified). The patient reported that on 06-JUL-2010, she found out she was pregnant. On 08-JUL-2010, the patient had a miscarriage. It was reported that since 11-AUG-2010, she had abnormal bleeding. The consumer stated that she had a period after her miscarriage but since GARDASIL was given it had caused her to have this abnormal bleeding. The patient also stated she had a miscarriage due to GARDASIL. The patient sought medical attention by visiting the hospital office. It was reported she would had an appointment with a physician on 17-AUG-2010. Additional information has been requested.
Body aches, moderate to extreme.  Chills.  Fever-101.3, then during the night.  Fever began about 4:00 pm on 2/18 and broke about 1:30 am on 2/19.
Patient in emergency room, asymptomatic at this time, had dystonic reactions after flu shot and family is unsure if related.